Packaged Foods
Build Your Comparison
Side-by-side financial analysisStock Comparison
MAMA vs BRBS vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Diversified
MAMA vs BRBS vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Packaged Foods | Banks - Regional | Banks - Diversified |
| Market Cap | $607M | $302M | $896.00B |
| Revenue (TTM) | $189M | $151M | $280.33B |
| Net Income (TTM) | $6M | $11M | $57.05B |
| Gross Margin | 24.5% | 63.5% | 60.0% |
| Operating Margin | 4.3% | 9.1% | 25.9% |
| Forward P/E | 139.7x | 30.0x | 14.4x |
| Total Debt | $14M | $179M | $942.38B |
| Cash & Equiv. | $20M | $116M | $343.34B |
MAMA vs BRBS vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | Jun 26 | Return |
|---|---|---|---|
| Mama's Creations, I… (MAMA) | 100 | 536.3 | +436.3% |
| Blue Ridge Bankshar… (BRBS) | 100 | 19.3 | -80.7% |
| JPMorgan Chase & Co. (JPM) | 100 | 211.3 | +111.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MAMA vs BRBS vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MAMA has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 39.2%, EPS growth 38.2%, 3Y rev CAGR 22.6%
- 5.2% 10Y total return vs JPM's 465.8%
- Lower volatility, beta 0.74, Low D/E 27.5%, current ratio 2.17x
BRBS is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 0 yrs, beta 0.48, yield 6.5%
- Beta 0.48, yield 6.5%
- NIM 3.2% vs JPM's 2.2%
JPM is the clearest fit if your priority is value and quality.
- Lower P/E (14.4x vs 139.7x), PEG 0.81 vs 86.59
- 20.4% margin vs MAMA's 3.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 39.2% revenue growth vs BRBS's -13.4% | |
| Value | Lower P/E (14.4x vs 139.7x), PEG 0.81 vs 86.59 | |
| Quality / Margins | 20.4% margin vs MAMA's 3.2% | |
| Stability / Safety | Beta 0.48 vs JPM's 0.94, lower leverage | |
| Dividends | 6.5% yield, vs JPM's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +87.3% vs BRBS's +21.0% | |
| Efficiency (ROA) | 7.9% ROA vs BRBS's 0.4%, ROIC 16.8% vs 2.0% |
MAMA vs BRBS vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MAMA vs BRBS vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 1861.3x BRBS's $151M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to MAMA's 3.2%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $189M | $151M | $280.3B |
| EBITDAEarnings before interest/tax | $14M | $15M | $81.4B |
| Net IncomeAfter-tax profit | $6M | $11M | $57.0B |
| Free Cash FlowCash after capex | $9M | $9M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +24.5% | +63.5% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +4.3% | +9.1% | +25.9% |
| Net MarginNet income ÷ Revenue | +3.2% | +7.1% | +20.4% |
| FCF MarginFCF ÷ Revenue | +4.8% | +6.1% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +49.7% | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +51.3% | +2.6% | +16.0% |
Valuation Metrics
JPM leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 86% valuation discount to MAMA's 114.7x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs MAMA's 71.07x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $607M | $302M | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $601M | $365M | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 114.69x | 30.00x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 139.74x | — | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | 71.07x | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 40.90x | 24.32x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 3.53x | 2.00x | 3.20x |
| Price / BookPrice ÷ Book value/share | 11.73x | 1.08x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 62.14x | 80.64x | 8.88x |
Profitability & Efficiency
MAMA leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $3 for BRBS. MAMA carries lower financial leverage with a 0.27x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), MAMA scores 6/9 vs JPM's 5/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +13.0% | +3.1% | +15.9% |
| ROA (TTM)Return on assets | +7.9% | +0.4% | +1.3% |
| ROICReturn on invested capital | +16.8% | +2.0% | +4.5% |
| ROCEReturn on capital employed | +17.7% | +0.5% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.27x | 0.55x | 2.60x |
| Net DebtTotal debt minus cash | -$5M | $63M | $599.0B |
| Cash & Equiv.Liquid assets | $20M | $116M | $343.3B |
| Total DebtShort + long-term debt | $14M | $179M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 16.57x | 0.23x | 0.74x |
Total Returns (Dividends Reinvested)
MAMA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MAMA five years ago would be worth $61,867 today (with dividends reinvested), compared to $2,958 for BRBS. Over the past 12 months, MAMA leads with a +87.3% total return vs BRBS's +21.0%. The 3-year compound annual growth rate (CAGR) favors MAMA at 76.8% vs BRBS's -23.2% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +15.3% | -9.1% | -0.5% |
| 1-Year ReturnPast 12 months | +87.3% | +21.0% | +21.8% |
| 3-Year ReturnCumulative with dividends | +452.2% | -54.7% | +138.2% |
| 5-Year ReturnCumulative with dividends | +518.7% | -70.4% | +118.2% |
| 10-Year ReturnCumulative with dividends | +518.7% | -15.5% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +76.8% | -23.2% | +33.6% |
Risk & Volatility
Evenly matched — BRBS and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
BRBS is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs BRBS's 68.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.74x | 0.48x | 0.94x |
| 52-Week HighHighest price in past year | $17.85 | $4.79 | $337.25 |
| 52-Week LowLowest price in past year | $7.75 | $3.23 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +83.5% | +68.9% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 52.6 | 45.7 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 427K | 335K | 7.0M |
Analyst Outlook
Evenly matched — BRBS and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MAMA as "Buy", JPM as "Buy". Consensus price targets imply 54.3% upside for MAMA (target: $23) vs 5.9% for JPM (target: $340). For income investors, BRBS offers the higher dividend yield at 6.45% vs JPM's 1.86%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy |
| Price TargetConsensus 12-month target | $23.00 | — | $339.75 |
| # AnalystsCovering analysts | 7 | — | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +6.5% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 15 |
| Dividend / ShareAnnual DPS | — | $0.21 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.1% | +3.9% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). MAMA leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
MAMA vs BRBS vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MAMA or BRBS or JPM a better buy right now?
For growth investors, Mama's Creations, Inc.
(MAMA) is the stronger pick with 39. 2% revenue growth year-over-year, versus -13. 4% for Blue Ridge Bankshares, Inc. (BRBS). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Mama's Creations, Inc. (MAMA) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MAMA or BRBS or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Mama's Creations, Inc. at 114. 7x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Mama's Creations, Inc. 's 86. 59x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MAMA or BRBS or JPM?
Over the past 5 years, Mama's Creations, Inc.
(MAMA) delivered a total return of +518. 7%, compared to -70. 4% for Blue Ridge Bankshares, Inc. (BRBS). Over 10 years, the gap is even starker: MAMA returned +518. 7% versus BRBS's -15. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MAMA or BRBS or JPM?
By beta (market sensitivity over 5 years), Blue Ridge Bankshares, Inc.
(BRBS) is the lower-risk stock at 0. 48β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 97% more volatile than BRBS relative to the S&P 500. On balance sheet safety, Mama's Creations, Inc. (MAMA) carries a lower debt/equity ratio of 27% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — MAMA or BRBS or JPM?
By revenue growth (latest reported year), Mama's Creations, Inc.
(MAMA) is pulling ahead at 39. 2% versus -13. 4% for Blue Ridge Bankshares, Inc. (BRBS). On earnings-per-share growth, the picture is similar: Blue Ridge Bankshares, Inc. grew EPS 135. 5% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MAMA or BRBS or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 3. 1% for Mama's Creations, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 4. 9% for MAMA. At the gross margin level — before operating expenses — BRBS leads at 63. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MAMA or BRBS or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Mama's Creations, Inc. 's 86. 59x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 139. 7x for Mama's Creations, Inc. — 125. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MAMA: 54. 3% to $23. 00.
08Which pays a better dividend — MAMA or BRBS or JPM?
In this comparison, BRBS (6.
5% yield), JPM (1. 9% yield) pay a dividend. MAMA does not pay a meaningful dividend and should not be held primarily for income.
09Is MAMA or BRBS or JPM better for a retirement portfolio?
For long-horizon retirement investors, Blue Ridge Bankshares, Inc.
(BRBS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 6. 5% yield). Both have compounded well over 10 years (BRBS: -15. 5%, MAMA: +518. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MAMA and BRBS and JPM?
These companies operate in different sectors (MAMA (Consumer Defensive) and BRBS (Financial Services) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MAMA is a small-cap high-growth stock; BRBS is a small-cap income-oriented stock; JPM is a large-cap deep-value stock. BRBS, JPM pay a dividend while MAMA does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.